Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression
在晚期慢性期和进展期伊马替尼敏感的慢性粒细胞白血病（CML）患者中发现新的复合型BCR-ABL突变，表明这些突变可能在CML进展中发挥作用。
期刊:Cancer Biology & Therapy
影响因子:4.6
doi:10.1080/15384047.2017.1294289
Akram, Afia Muhammad; Iqbal, Zafar; Akhtar, Tanveer; Khalid, Ahmed Mukhtar; Sabar, Muhammad Farooq; Qazi, Mahmood Hussain; Aziz, Zeba; Sajid, Nadia; Aleem, Aamer; Rasool, Mahmood; Asif, Muhammad; Aloraibi, Saleh; Aljamaan, Khaled; Iqbal, Mudassar
